Skip to main content
. 2020 Jul 28;10(8):1113. doi: 10.3390/biom10081113

Figure 2.

Figure 2

Figure 2

Biomarker levels in pleural effusion of malignant pleural mesothelioma (MPM) patients compared to benign effusions (BE). (AH) Levels of Galectin-1, Mesothelin, Osteopontin, shed SDC-1, VEGF, MMP-7, HGF and TIMP-1 are significantly higher in pleural effusion from malignant pleural mesothelioma (MPM) patients (n = 42) comparing with benign (BE) patients (n = 40). (I) Level of NRG1-β1 is significantly lower Significance was assessed by two-tailed t-test at p ≤ 0.05.